Shuttle Pharmaceuticals Insider Trading Activity | NASDAQ:SHPH

Comments

Shuttle Pharmaceuticals Holdings Inc Insider Trading Activity

SHPHNASDAQ

Trade with Public

$0.9400

0.01371.48%

At close: Mar 13, 5:00 PM EST

$0.9400

N/A

After Hours: Mar 13, 6:09 PM EST

Overview News EarningsInsider TradesShort Interest Stock Report

Shuttle Pharmaceuticals Insider Trading Activity | NASDAQ:SHPH | Benzinga

Track the latest Shuttle Pharmaceuticals insider trading activity. Stay informed on recent buys, sells, and market impact for Shuttle Pharmaceuticals stock.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are Shuttle Pharmaceuticals Holdings Inc Insiders Doing?

Insiders have report no purchases/sales in the last 30 days.

Notable Recent Insider Buys and Sales

There has been no Insider buying or selling in the last 90 days.

Ownership Statistics for Shuttle Pharmaceuticals Holdings Inc

Loading calendar...

FAQ

Is insider trading legal?

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.

What are some examples of market manipulation?

Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

SHPH Insider Trading News

No news found

People Also Watch

Dermata Therapeutics Inc

NASDAQ:DRMA

$1.19

Ernexa Therapeutics Inc

AquaBounty Technologies Inc

NASDAQ:AQB

$0.96

2.00%

Indaptus Therapeutics Inc

Ensysce Biosciences Inc

NASDAQ:ENSC

$0.41

-0.39%

Shuttle Pharmaceuticals Insider Trading Activity | NASDAQ:SHPH | Benzinga

Track the latest Shuttle Pharmaceuticals insider trading activity. Stay informed on recent buys, sells, and market impact for Shuttle Pharmaceuticals stock.

What is Insider Activity?

What are Shuttle Pharmaceuticals Holdings Inc Insiders Doing?

Insiders have report no purchases/sales in the last 30 days.

Notable Recent Insider Buys and Sales

There has been no Insider buying or selling in the last 90 days.

Ownership Statistics for Shuttle Pharmaceuticals Holdings Inc


Mar 14, 2024	Chris Senanayake	DIRECTOR	-1.63K	$1.60	-$2.61K	SELL	-36.81%	2.79K	Dec 29	View
Jan 02, 2024	Milton Brown	DIRECTOR	-2.92K	$0.46	-$1.35K	SELL	-0.27%	1.09M	Dec 13	View
Dec 20, 2023	Bette Jacobs	DIRECTOR	-4.16K	$0.46	-$1.93K	SELL	-13.31%	27.06K	Dec 13	View
Jan 09, 2023	Steven Richards	DIRECTOR	-995.00	$1.60	-$1.60K	SELL	-36.82%	1.71K	Dec 29	View
Jan 04, 2023	William Adkins	—	-995.00	$1.60	-$1.60K	SELL	-0.54%	184.07K	Dec 29	View
Jan 04, 2023	Milton Brown	DIRECTOR	-995.00	$1.60	-$1.60K	SELL	-0.09%	1.07M	Dec 29	View
Jan 03, 2023	Anatoly Dritschilo	CEO AND CHAIRMAN	-8.37K	$1.60	-$13.44K	SELL	-0.19%	4.29M	Dec 29	View
Jan 03, 2023	Tyvin Rich	CHIEF MEDICAL OFFICER	-1.41K	$1.60	-$2.27K	SELL	-36.79%	2.43K	Dec 29	View
Jan 03, 2023	Mira Jung	CHIEF SCIENTIFIC OFFICER	-328.00	$1.60	-$526.44	SELL	-0.03%	1.07M	Dec 29	View
Jan 03, 2023	Bette Jacobs	DIRECTOR	-4.37K	$1.60	-$7.01K	SELL	-12.27%	31.22K	Dec 29	View
Dec 30, 2022	Peter Dritschilo	PRESIDENT AND COO	-3.82K	$1.61	-$6.13K	SELL	-36.80%	6.56K	Dec 29	View
Dec 30, 2022	Michael Vander Hoek	CHIEF FINANCIAL OFFICER	-2.24K	$1.60	-$3.60K	SELL	-36.80%	3.85K	Dec 29	View

Loading calendar...

FAQ

Is insider trading legal?

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.

What are some examples of market manipulation?

SHPH Insider Trading News

No news found

People Also Watch

Dermata Therapeutics Inc

NASDAQ:DRMA

$1.19

Ernexa Therapeutics Inc

AquaBounty Technologies Inc

NASDAQ:AQB

$0.96

2.00%

Indaptus Therapeutics Inc

Ensysce Biosciences Inc

NASDAQ:ENSC

$0.41

-0.39%


Mar 14, 2024	Chris Senanayake	DIRECTOR	-1.63K	$1.60	-$2.61K	SELL	-36.81%	2.79K	Dec 29	View
Jan 02, 2024	Milton Brown	DIRECTOR	-2.92K	$0.46	-$1.35K	SELL	-0.27%	1.09M	Dec 13	View
Dec 20, 2023	Bette Jacobs	DIRECTOR	-4.16K	$0.46	-$1.93K	SELL	-13.31%	27.06K	Dec 13	View
Jan 09, 2023	Steven Richards	DIRECTOR	-995.00	$1.60	-$1.60K	SELL	-36.82%	1.71K	Dec 29	View
Jan 04, 2023	William Adkins	—	-995.00	$1.60	-$1.60K	SELL	-0.54%	184.07K	Dec 29	View
Jan 04, 2023	Milton Brown	DIRECTOR	-995.00	$1.60	-$1.60K	SELL	-0.09%	1.07M	Dec 29	View
Jan 03, 2023	Anatoly Dritschilo	CEO AND CHAIRMAN	-8.37K	$1.60	-$13.44K	SELL	-0.19%	4.29M	Dec 29	View
Jan 03, 2023	Tyvin Rich	CHIEF MEDICAL OFFICER	-1.41K	$1.60	-$2.27K	SELL	-36.79%	2.43K	Dec 29	View
Jan 03, 2023	Mira Jung	CHIEF SCIENTIFIC OFFICER	-328.00	$1.60	-$526.44	SELL	-0.03%	1.07M	Dec 29	View
Jan 03, 2023	Bette Jacobs	DIRECTOR	-4.37K	$1.60	-$7.01K	SELL	-12.27%	31.22K	Dec 29	View
Dec 30, 2022	Peter Dritschilo	PRESIDENT AND COO	-3.82K	$1.61	-$6.13K	SELL	-36.80%	6.56K	Dec 29	View
Dec 30, 2022	Michael Vander Hoek	CHIEF FINANCIAL OFFICER	-2.24K	$1.60	-$3.60K	SELL	-36.80%	3.85K	Dec 29	View